INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 452m ago
HOUSE PTR52m ago
SEC 13F51m ago
ROBINHOOD CHAIN51m ago
Public company

VVOSVivos Therapeutics, Inc.

CIK 0001716166

EDGAR filingsOpen in network
Disclosed transactions7
Buys / sells5 / 0
Max Insider Score50
Connections6with evidence

VVOS · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
31
LF
Lindsay Mark F.Director
VVOSVivos Therapeutics, Inc.
Grant or award
A—
12.0K sh
Sep 14, 2026Oct 26, 2026
traded Sep 14, 2026
+42dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 3841 · Surgical & Medical Instruments & Apparatus · Nov 4, 2026
  • ← Insider ofevidence
    Lindsay Mark F.Director · Oct 26, 2026
  • ← Insider ofevidence
    Green Ralph EliasDirector · Oct 26, 2026
  • ← Lobbied forevidence
    BELL & LINDSAY, INC.LDA Q2 2026 second quarter · Health issues · Aug 26, 2026
31
GE
Green Ralph EliasDirector
VVOSVivos Therapeutics, Inc.
Grant or award
A
—
12.0K sh
Sep 14, 2026
Oct 26, 2026
traded Sep 14, 2026
+42d
SEC FORM 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

47
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$576K
430.0K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$2.39M
1.78M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

50
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$1.40M
1.04M sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

43
SC
Skaff Michael C10% Owner
VVOSVivos Therapeutics, Inc.
Open-market purchase
BUY$414K
308.8K sh
Mar 31, 2026Apr 2, 2026
traded Mar 31, 2026
+2dSEC FORM 4

Evidence

  • ← Insider ofevidence
    Skaff Michael C10% Owner · Apr 2, 2026
  • ← Insider ofevidence
    V-Co Investors 3 LLC10% Owner · Apr 2, 2026

    • Lobbying

    $80K reported · de-duplicated
    2026 Q2 $40K via firms2026 Q1 $40K via firms
    • BELL & LINDSAY, INC.$40K2026 Q1 · posted Aug 26, 2026 · Health issues
    • BELL & LINDSAY, INC.$40K2026 Q2 · posted Aug 26, 2026 · Health issues

    Connected PAC contributions

    FEC · direct to members

    No contributions from a PAC connected to this company.